Kim DY - Search Results

1

Gastric Carcinogenesis in the miR-222/221 Transgenic Mouse Model.

Choi B, Yu J, Han TS, Kim YK, Hur K, Kang BC, Kim WH, Kim DY, Lee HJ, Kim VN, Yang HK. Choi B, et al. Among authors: kim wh, kim yk, kim dy, kim vn. Cancer Res Treat. 2017 Jan;49(1):150-160. doi: 10.4143/crt.2015.462. Epub 2016 Jun 23. Cancer Res Treat. 2017. PMID: 27338035 Free PMC article.

2

Downregulation of gelsolin and retinoic acid receptor beta expression in gastric cancer tissues through histone deacetylase 1.

Kim JH, Choi YK, Kwon HJ, Yang HK, Choi JH, Kim DY. Kim JH, et al. Among authors: kim dy. J Gastroenterol Hepatol. 2004 Feb;19(2):218-24. doi: 10.1111/j.1440-1746.2004.03336.x. J Gastroenterol Hepatol. 2004. PMID: 14731134

3

The selective cyclooxygenase-2 inhibitor nimesulide prevents Helicobacter pylori-associated gastric cancer development in a mouse model.

Nam KT, Hahm KB, Oh SY, Yeo M, Han SU, Ahn B, Kim YB, Kang JS, Jang DD, Yang KH, Kim DY. Nam KT, et al. Among authors: kim dy, kim yb. Clin Cancer Res. 2004 Dec 1;10(23):8105-13. doi: 10.1158/1078-0432.CCR-04-0896. Clin Cancer Res. 2004. PMID: 15585646

4

Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.

You MH, Kim WJ, Shim W, Lee SR, Lee G, Choi S, Kim DY, Kim YM, Kim H, Han SU. You MH, et al. Among authors: kim h, kim wj, kim ym, kim dy. J Gastroenterol Hepatol. 2009 Aug;24(8):1393-400. doi: 10.1111/j.1440-1746.2009.05862.x. Epub 2009 May 28. J Gastroenterol Hepatol. 2009. PMID: 19486256

5

Canonical Wnt signaling pathway plays an essential role in N-methyl-N-nitrosurea induced gastric tumorigenesis of mice.

Heo SH, Jeong ES, Lee KS, Seo JH, Jeong DG, Won YS, Kwon HJ, Kim HC, Kim DY, Choi YK. Heo SH, et al. Among authors: kim dy, kim hc. J Vet Med Sci. 2013;75(3):299-307. doi: 10.1292/jvms.12-0233. Epub 2012 Oct 30. J Vet Med Sci. 2013. PMID: 23117827 Free article.

6

Connexin32 inhibits gastric carcinogenesis through cell cycle arrest and altered expression of p21Cip1 and p27Kip1.

Jee H, Lee SH, Park JW, Lee BR, Nam KT, Kim DY. Jee H, et al. Among authors: kim dy. BMB Rep. 2013 Jan;46(1):25-30. doi: 10.5483/bmbrep.2013.46.1.078. BMB Rep. 2013. PMID: 23351380 Free PMC article.

7

Preclinical efficacy testing for stomach and liver cancers.

Park JW, Baek NS, Lee SC, Oh SJ, Jang SH, Kim IH, Kim DY, Kim HK. Park JW, et al. Among authors: kim ih, kim hk, kim dy. Cancer Res Treat. 2014 Apr;46(2):186-93. doi: 10.4143/crt.2014.46.2.186. Epub 2014 Apr 22. Cancer Res Treat. 2014. PMID: 24851111 Free PMC article.

8

Overexpression of urokinase-type plasminogen activator in human gastric cancer cell line (AGS) induces tumorigenicity in severe combined immunodeficient mice.

Choi YK, Yoon BI, Kook YH, Won YS, Kim JH, Lee CH, Hyun BH, Oh GT, Sipley J, Kim DY. Choi YK, et al. Among authors: kim dy, kim jh. Jpn J Cancer Res. 2002 Feb;93(2):151-6. doi: 10.1111/j.1349-7006.2002.tb01253.x. Jpn J Cancer Res. 2002. PMID: 11856478 Free PMC article.

9

Helicobacter pylori infection promotes gastric carcinogenesis in a mice model.

Han SU, Kim YB, Joo HJ, Hahm KB, Lee WH, Cho YK, Kim DY, Kim MW. Han SU, et al. Among authors: kim dy, kim yb, kim mw. J Gastroenterol Hepatol. 2002 Mar;17(3):253-61. doi: 10.1046/j.1440-1746.2002.02684.x. J Gastroenterol Hepatol. 2002. PMID: 11982694

10

Involvement of Kv4.1 K(+) channels in gastric cancer cell proliferation.

Kim HJ, Jang SH, Jeong YA, Ryu PD, Kim DY, Lee SY. Kim HJ, et al. Among authors: kim dy. Biol Pharm Bull. 2010;33(10):1754-7. doi: 10.1248/bpb.33.1754. Biol Pharm Bull. 2010. PMID: 20930388 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,133 results

Search Page